Research ID
hum0383-v1Release info
Research title
Analysis of the effect of abatacept for the transcriptome of multiple lymphoid subsets
Research overview
- Aims
- To elucidate the mechanism and predictors of abatacept, a CTLA4 agonist that regulates T cell co-stimulation, in rheumatoid arthritis (RA) treatment.
- Methods
- Various peripheral blood immune cell subsets from 5 RA patients were collected (CD16p_Mono, CL_Mono, DN_B, Fr_II_eTreg, mDC, Mem_CD4, Naive_B, Naive_CD4, Neu, NK, pDC, Plasmablast, SM_B, Tfh, Th1, Th17, Th2, USM_B). The patients were analyzed again longitudinally after abatacept treatment. RNA-seq was performed with each immune cell subset sample.
- Participants/materials
- 5 RA patients
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000731 | NGS (RNA-seq) |
| Controlled-access (Type I) | 2023-03-27 |
Data provider
- Principal investigator
- Keishi Fujio
- Affiliation
- Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo
Research projects
| Name | URL |
|---|---|
Analysis of the effect of abatacept for the transcriptome of multiple lymphoid subsets |
Grants
| Name | Title | Project number |
|---|---|---|
Collaborative research fund with Bristol Myers Squibb Japan | Analysis of the effect of abatacept for the transcriptome of multiple lymphoid subsets | N/A |
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance |
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 | |
| Shimpei Kubota | Molecular Psychoneuroimmunology, Hokkaido University | Japan | Gene expression and IL-6 amplifying circuit activators in rheumatoid arthritis and systemic lupus erythematosus | 2024-02-26 – 2026-03-31 | |
| Pranidhi Sood | Wield Therapeutics, Inc | California, United States | Identifying Gene Expression Based Biomarkers in Patients with Autoimmune Diseases to Predict Response to New Therapies Developed by Wield Therapeutics | 2025-06-25 – 2027-04-23 |